Showing results (301-310 of 471) with videos related to
Sort By:
Pageof 48
Biomaterials|October 14, 2021
Tumor-activatable biomineralized nanotherapeutics for integrative glucose starvation and sensitized metformin therapyHong Wen, Yang Fei, Ruisi Cai, et al.Nanoscale|January 31, 2015
Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivoJunjie Liu, Beilu Zhang, Zhong Luo, et al.Sensors (Basel, Switzerland)|February 10, 2024
An Adaptive Deconvolution Method with Improve Enhanced Envelope Spectrum and Its Application for Bearing Fault Feature ExtractionFengxia He, Chuansheng Zheng, Chao Pang, et al.ACS Nano|July 22, 2026
Intra-Articularly Injectable Ion-Coordinated Bionic Lubricants Improve Rheumatoid Arthritis Recession via Pro-Regenerative Reprogramming of Synovial MacrophagesJiayi Lin, Junyi Li, Yue Wu, et al.Archives of Microbiology|August 5, 2026
Viral persistence and host-state remodeling in virus-associated cancersJiaqi Ma, Jianchao Guo, Guohao Li, et al.Journal of Biomedical Materials Research. Part A|January 30, 2016
Enhancement of local bone remodeling in osteoporotic rabbits by biomimic multilayered structures on Ti6Al4V implantsLing Huang, Zhong Luo, Yan Hu, et al.Biomaterials|November 3, 2024
Nanoradiosentizers with X ray-actuatable supramolecular aptamer building units for programmable immunostimulatory T cell engagementJinming He, Xijiao Ren, Qiqi Zhang, et al.Acta Biomaterialia|August 6, 2023
Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatmentZhuo Cheng, Chencheng Xue, Minghan Liu, et al.Acta Biomaterialia|July 29, 2023
Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapyJiawu Yu, Yuchen Zhang, Liqi Li, et al.Biochemical and Biophysical Research Communications|March 30, 2020
Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxelKe Li, Menghuan Li, Zhong Luo, et al.Pageof 48